NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
About NEONC TECHNOLOGIES HOLDINGS, INC.
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $40.0K
- Net income
- -$62.1M
- Total assets
- $2.8M
- Market cap
- $115.0M
- Operating margin
- -145637.5%
- Net margin
- -155404.4%
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $40.0K
- Operating expenses
- $58.3M
- Operating income
- -$58.2M
- Net income
- -$62.1M
- EPS (basic)
- $-3.20
- EPS (diluted)
- $-3.20
Balance sheet
- Total assets
- $2.8M
- Current assets
- $1.4M
- Total liabilities
- $20.3M
- Current liabilities
- $20.0M
- Shareholders’ equity
- -$17.5M
Cash flow
- Operating cash flow
- -$20.4M
- Investing cash flow
- -$493.8K
- Financing cash flow
- $20.9M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $115.0M
- EPS (diluted)
- $-3.2
- Shares outstanding
- 33.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 26, 2025
Neonc Technologies Holdings, Inc. (NTHI) Stock Price
- Reported a net loss of $62.1M in FY2025.
- Trading 72% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review NEONC TECHNOLOGIES HOLDINGS, INC..
Write a review
News about NEONC TECHNOLOGIES HOLDINGS, INC.
News & sentiment via Polygon.io
Neonc Technologies Holdings, Inc.: frequently asked questions
Is Neonc Technologies Holdings, Inc. an American company?
Neonc Technologies Holdings, Inc. is a US-based company headquartered in Calabasas, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Neonc Technologies Holdings, Inc. headquartered?
Neonc Technologies Holdings, Inc. is headquartered in Calabasas, California, United States.
Is Neonc Technologies Holdings, Inc. publicly traded?
Yes — Neonc Technologies Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol NTHI on the NASDAQ.
What does Neonc Technologies Holdings, Inc. do?
Neonc Technologies Holdings, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
